Phadke Shubha R, Agarwal Savita
Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Indian J Pediatr. 2003 Jun;70(6):477-81. doi: 10.1007/BF02723137.
Thalassemia intermedia is an ill-defined group of thalassemia patients with severity in between thalassemia major and asymptomatic carriers. The severity of cases varies greatly. With availability of information about genetic modifiers of beta-thalassemia phenotype, attempts are being made to study genotype phenotype correlation in thalassemia intermedia.
The first important step in genotype, phenotype correlation is well-defined phenotypes. Severity of thalassemia intermedia can not be graded only on haemoglobin level and age of presentation. The authors have developed a phenotype scoring system to subclassify thalassemia intermedia patients into 3 groups, viz, mild, moderate and severe.
This phenotype scoring system appears to grade the severity correctly depending on various clinical features like age of presentation, severity of anaemia, growth retardation, bone marrow hyperplasia, need of blood transfusions and splenectomy.
The classification of thalassemia intermedia will be useful for genotype phenotype correlation, to develop management guidelines for the subgroups and to try new treatment modalities like hydroxyurea, erythropoetin etc.
中间型地中海贫血是一组定义不明确的地中海贫血患者,其严重程度介于重型地中海贫血和无症状携带者之间。病例的严重程度差异很大。随着有关β地中海贫血表型遗传修饰因子信息的可得性,人们正在尝试研究中间型地中海贫血的基因型-表型相关性。
基因型与表型相关性研究的首要重要步骤是明确的表型。中间型地中海贫血的严重程度不能仅根据血红蛋白水平和发病年龄来分级。作者开发了一种表型评分系统,将中间型地中海贫血患者分为3组,即轻度、中度和重度。
这种表型评分系统似乎能根据发病年龄、贫血严重程度、生长发育迟缓、骨髓增生、输血需求和脾切除术等各种临床特征正确地对严重程度进行分级。
中间型地中海贫血的分类对于基因型-表型相关性研究、制定亚组管理指南以及尝试羟基脲、促红细胞生成素等新的治疗方式将是有用的。